207 related articles for article (PubMed ID: 27622030)
1. The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27.
d'Almeida SM; Kauffenstein G; Roy C; Basset L; Papargyris L; Henrion D; Catros V; Ifrah N; Descamps P; Croue A; Jeannin P; Grégoire M; Delneste Y; Tabiasco J
Oncoimmunology; 2016 Jul; 5(7):e1178025. PubMed ID: 27622030
[TBL] [Abstract][Full Text] [Related]
2. Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape.
Montalbán Del Barrio I; Penski C; Schlahsa L; Stein RG; Diessner J; Wöckel A; Dietl J; Lutz MB; Mittelbronn M; Wischhusen J; Häusler SFM
J Immunother Cancer; 2016; 4():49. PubMed ID: 27532024
[TBL] [Abstract][Full Text] [Related]
3. CD39
Ahlmanner F; Sundström P; Akeus P; Eklöf J; Börjesson L; Gustavsson B; Lindskog EB; Raghavan S; Quiding-Järbrink M
Oncotarget; 2018 Dec; 9(97):36993-37007. PubMed ID: 30651930
[TBL] [Abstract][Full Text] [Related]
4. Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways.
Giatromanolaki A; Kouroupi M; Pouliliou S; Mitrakas A; Hasan F; Pappa A; Koukourakis MI
Life Sci; 2020 Oct; 259():118389. PubMed ID: 32898522
[TBL] [Abstract][Full Text] [Related]
5. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
6. Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro.
Benner B; Scarberry L; Suarez-Kelly LP; Duggan MC; Campbell AR; Smith E; Lapurga G; Jiang K; Butchar JP; Tridandapani S; Howard JH; Baiocchi RA; Mace TA; Carson WE
J Immunother Cancer; 2019 May; 7(1):140. PubMed ID: 31138333
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating CD39
Hu G; Wu P; Cheng P; Zhang Z; Wang Z; Yu X; Shao X; Wu D; Ye J; Zhang T; Wang X; Qiu F; Yan J; Huang J
Oncoimmunology; 2017; 6(2):e1277305. PubMed ID: 28344891
[TBL] [Abstract][Full Text] [Related]
9. Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages.
Puig-Kröger A; Sierra-Filardi E; Domínguez-Soto A; Samaniego R; Corcuera MT; Gómez-Aguado F; Ratnam M; Sánchez-Mateos P; Corbí AL
Cancer Res; 2009 Dec; 69(24):9395-403. PubMed ID: 19951991
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
Kashyap AS; Thelemann T; Klar R; Kallert SM; Festag J; Buchi M; Hinterwimmer L; Schell M; Michel S; Jaschinski F; Zippelius A
J Immunother Cancer; 2019 Mar; 7(1):67. PubMed ID: 30871609
[TBL] [Abstract][Full Text] [Related]
11. CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8
Canale FP; Ramello MC; Núñez N; Araujo Furlan CL; Bossio SN; Gorosito Serrán M; Tosello Boari J; Del Castillo A; Ledesma M; Sedlik C; Piaggio E; Gruppi A; Acosta Rodríguez EA; Montes CL
Cancer Res; 2018 Jan; 78(1):115-128. PubMed ID: 29066514
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of ecto-nucleoside triphosphate diphosphohydrolase 1 (CD39) involved in regulating extracellular ATP-mediated innate immune responses in Japanese flounder (Paralichthys olivaceus).
Li S; Chen X; Wang N; Li J; Feng Y; Sun J
Mol Immunol; 2019 Aug; 112():10-21. PubMed ID: 31075558
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages.
Duluc D; Corvaisier M; Blanchard S; Catala L; Descamps P; Gamelin E; Ponsoda S; Delneste Y; Hebbar M; Jeannin P
Int J Cancer; 2009 Jul; 125(2):367-73. PubMed ID: 19378341
[TBL] [Abstract][Full Text] [Related]
14. Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor models.
Zhang H; Feng L; de Andrade Mello P; Mao C; Near R; Csizmadia E; Chan LL; Enjyoji K; Gao W; Zhao H; Robson SC
J Clin Invest; 2022 Jul; 132(13):. PubMed ID: 35775486
[TBL] [Abstract][Full Text] [Related]
15. Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection.
Kim K; Perera R; Tan DB; Fernandez S; Seddiki N; Waring J; French MA
Tuberculosis (Edinb); 2014 Sep; 94(5):494-501. PubMed ID: 25095750
[TBL] [Abstract][Full Text] [Related]
16. Extracellular ATP inhibits IL-1-induced MMP-1 expression through the action of CD39/nucleotidase triphosphate dephosphorylase-1 on human gingival fibroblasts.
Nemoto E; Gotoh K; Tsuchiya M; Sakisaka Y; Shimauchi H
Int Immunopharmacol; 2013 Nov; 17(3):513-8. PubMed ID: 23941770
[TBL] [Abstract][Full Text] [Related]
17. CD39 (ENTPD1) in tumors: a potential therapeutic target and prognostic biomarker.
Li C; Zhang L; Jin Q; Jiang H; Wu C
Biomark Med; 2023 Jun; 17(12):563-576. PubMed ID: 37713234
[TBL] [Abstract][Full Text] [Related]
18. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
[TBL] [Abstract][Full Text] [Related]
19. Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism.
Kaneider NC; Egger P; Dunzendorfer S; Noris P; Balduini CL; Gritti D; Ricevuti G; Wiedermann CJ
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):894-900. PubMed ID: 12067895
[TBL] [Abstract][Full Text] [Related]
20. Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release.
Sierra-Filardi E; Vega MA; Sánchez-Mateos P; Corbí AL; Puig-Kröger A
Immunobiology; 2010; 215(9-10):788-95. PubMed ID: 20580464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
